FYidoctors is pleased to announce their significant purchase of CIRRUS™ HD-OCTs from Carl Zeiss Canada. This current technology system offers tools to aid in the management of glaucoma, retinal disease and anterior segment imaging for corneal disease.
CIRRUS HD-OCT will revolutionize early detection of common eye conditions and help FYidoctors manage disease, vastly improving coverage in our clinics from Coast to Coast.
With over 160 years of innovation and as the creator of the OCT technology, ZEISS has over 10,000 OCTs in the market. ZEISS strives to serve doctors with complete solutions to support better workflows.
“For many years we have been a trusted partner for the eye care specialist looking for advanced diagnosis and treatment devices offering them complete solutions for optimal workflows to enhance patient care. We are pleased FYidoctors has chosen ZEISS as a trusted partner for OCTs”, said Moosah Gulam, Vice President of the Medical Division at Carl Zeiss Canada.
Dr. Alan Ulsifer, CEO and President of FYidoctors added, “Commitment to eye care and technology is simply part of who we are. This purchase is not just part of our ongoing dedication to our patients well-being, but also a big part of our brand.”
By bringing the CIRRUS technology into its offices, FYidoctors and ZEISS are working together to improve and advance patient care.
For more information about what CIRRUS HD-OCT technology can do for you, speak to your nearest FYidoctors optometrist.